Back to Journals » Drug Design, Development and Therapy » Volume 20
Patient-Controlled Sedation with Remimazolam Enables More Precise Intraoperative Sedation in Elderly Patients Under Spinal Anesthesia: A Randomized Controlled Trial [Corrigendum]
Wang M, Wang T, Wu N, et al. Drug Des Devel Ther. 2016;20:1–14. https://doi.org/10.2147/DDDT.S573714
Page 6, Adverse Events and Satisfaction with Sedation section, last line, the text “One patient (1.7%) in the CS group developed postoperative delirium within 2 hours” should not have been included in the published paper.
Page 7, Adverse Events and Satisfaction with Sedation section, second line, the text “or delirium” should not have been included in the published paper.
The last two sentences of the Adverse Events and Satisfaction with Sedation section should read as “No significant differences were observed in the overall incidence of intraoperative adverse events between the two groups (P > 0.05). No significant differences were found between the groups in the incidence of postoperative nausea and vomiting, dizziness, headache, or somnolence within 2 hours after surgery (P > 0.05) (Table 2)”.
The authors apologize for this error.
© 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.